Versartis, Inc. (VSAR) Stock Analysis
DELISTED 2018
What happened to Versartis, Inc. (VSAR) stock?
Versartis, Inc. (VSAR) no longer trades on public markets. It was delisted in October 2018. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- October 2018
- Last recorded price (historical):
- $1.19 (last quote on record before the October 2018 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Versartis, Inc. (VSAR). Versartis, Inc. was a biopharmaceutical company focused on developing somavaratan, a long-acting recombinant human growth hormone, for endocrine disorders, primarily growth hormone deficiency.
Last analyzed: Jun 14, 2026Versartis, Inc. (VSAR) Healthcare & Pipeline Overview
More about this archive record
Can I still buy VSAR shares?
No. VSAR stopped trading on public markets in October 2018, so the shares are not available through a broker. Anything you see quoted for VSAR elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before VSAR stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Versartis, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.